tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Panel orders GLP-1 drug lawsuits to be centralized, Reuters reports
PremiumThe FlyPanel orders GLP-1 drug lawsuits to be centralized, Reuters reports
5d ago
Eli Lilly upgraded to Buy from Neutral at Daiwa
Premium
The Fly
Eli Lilly upgraded to Buy from Neutral at Daiwa
5d ago
Eli Lilly price target raised to $1,145 from $951 at Goldman Sachs
Premium
The Fly
Eli Lilly price target raised to $1,145 from $951 at Goldman Sachs
6d ago
Midday Fly By: Broadcom slides, pot stocks jump
PremiumThe FlyMidday Fly By: Broadcom slides, pot stocks jump
9d ago
Eli Lilly announces updated results from Phase 3 EMBER-3 study of Inluriyo
Premium
The Fly
Eli Lilly announces updated results from Phase 3 EMBER-3 study of Inluriyo
9d ago
FDA speeding review of Eli Lilly’s weight loss pill, Reuters reports
Premium
The Fly
FDA speeding review of Eli Lilly’s weight loss pill, Reuters reports
9d ago
Morning Movers: Oracle continues to slide despite earnings beat
PremiumThe FlyMorning Movers: Oracle continues to slide despite earnings beat
10d ago
Eli Lilly reports TRIUMPH-4 trial of retatrutide met primary endpoint
Premium
The Fly
Eli Lilly reports TRIUMPH-4 trial of retatrutide met primary endpoint
10d ago
Eli Lilly’s Strategic Advancements in Incretin Pipeline and Diversification Drive Buy Rating
Premium
Ratings
Eli Lilly’s Strategic Advancements in Incretin Pipeline and Diversification Drive Buy Rating
10d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100